Pharmacoeconomic analyses: whose perspective counts and costs the most?
Rubenstein, E.B.; Elting, L.S.
American Journal of Hospital Pharmacy 51(12): 1564-1569
1994
ISSN/ISBN: 0002-9289 PMID: 8092157 Document Number: 423221
Document emailed within 1 workday
Related Documents
Tanaka, K.; Kaetsu, T.; Suzuki, S.; Kusano, M.; Yajima, S.; Sakamaki, H.; Ikeda, S.; Ikegami, N.; Murayama, J-Ichiro. 2003: Pharmacoeconomic study of chemotherapy for gastric cancer: analysis of medical costs for oral fluoropyrimidine TS-1 and conventional i.v therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(1): 73-80Bol'shakova, T.D.; Aleksandrovskaia, T.N.; Sitnikova, L.A.; Solov'ev, L.S.; Lukicheva, T.I.; Fel'shina, E.I. 1990: Some approaches to the calculation of the intralaboratory costs of analyses in an automated laboratory Laboratornoe Delo 2: 58-61
Titus, P.H. 2000: Structural analyses, sensivity analyses, and independent confirmatory analyses of the IGNITOR magnet system Ieee Trans. Appl. Supercond 10(1): 641-644
Reece, R.L. 1979: Organizing to contain health care costs: the Minnesota medical perspective Journal of the Medical Society of New Jersey 76(4): 273-277
Xie, J.; Qiu, Z.; Han, Y.; Li, Y.; Song, X.; Li, T. 2015: A multicenter study of correlation between peripheral lymphocyte counts and CD(+)4T cell counts in HIV/AIDS patients Zhonghua Nei Ke Za Zhi 54(2): 118-121
Hervás-Angulo, A.; Cabasés-Hita, J.M.; Forcén-Alonso, T. 2006: Costs deriving from strokes from a social perspective. A retrospective incidence approach with a follow-up at three years Revista de Neurologia 43(9): 518-525
Clarke, A.E.; Petri, M.A.; Manzi, S.; Isenberg, D.A.; Gordon, C.; Senecal, J.L.; St Pierre, Y.; Joseph, L.; Penrod, J.; Fortin, P.R.; Sutcliffe, N.; Goulet, J.R.; Choquette, D.; Grodzicky, T.; Danoff, D.S.; Ho, V.; Esdaile, J.M. 1999: An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group Journal of Rheumatology 26(7): 1500-1511
Burgess, E.D.; Carides, G.W.; Gerth, W.C.; Marentette, M.A.; Chabot, I. 2004: Losartan reduces the costs associated with nephropathy and end-stage renal disease from type 2 diabetes: Economic evaluation of the RENAAL study from a Canadian perspective Canadian Journal of Cardiology 20(6): 613-618
Alarcón, G.S.; Tilley, B.C.; Li, S.; Fowler, S.E.; Pillemer, S.R. 1999: Self-administered joint counts and standard joint counts in the assessment of rheumatoid arthritis. MIRA Trial Group. Minocycline in RA Journal of Rheumatology 26(5): 1065-1067
Jerome, D.; Laurent, C.; Catherine, B.; Didier, S.; Bertrand, C.; Muriel, R.; Joseph, M.; Olivier, Z.; Thiery, P.; Claude, C.J.an 2002: Costs of hospital management of hepatitis C virus cirrhosis in France Comparison between real costs and diagnosis related groups based costs Results of a multicentric study carried out on 267 consecutive patients in 1998 Hepatology 36(4 Part 2): 587A
Islam, Z.; Sarker, A.R.; Anwar, S.; Kabir, H.; Gazi, R. 2015: Costs of integrating demand-based reproductive health commodity model into the Government and NGO service delivery systems in Bangladesh: a supply side perspective Springerplus 4: 808
Von Ferber, L.; Köster, I.; Hauner, H. 1996: Direct costs of ambulatory treatment of diabetes mellitus. Comparison of observed costs with estimated costs of adherence to the treatment standard Medizinische Klinik 91(12): 802-808
Hazarika, G. 2001: The Sensitivity of Primary School Enrollment to the Costs of Post-Primary Schooling in Rural Pakistan: a Gender Perspective Education Economics 9(3): 237-244
Brenner, M.H. 1983: Mortality and economic instability: detailed analyses for Britain and comparative analyses for selected industrialized countries International Journal of Health Services: Planning Administration Evaluation 13(4): 563-620
Van Cott, E.M.; Lewandrowski, K.B.; Patel, S.; Grzybek, D.Y.; Patel, H.S.; Fletcher, S.R.; Kratz, A. 2003: Comparison of glass K3EDTA versus plastic K2EDTA blood-drawing tubes for complete blood counts, reticulocyte counts, and white blood cell differentials Laboratory Hematology: Official Publication of the International Society for Laboratory Hematology 9(1): 10-14
Taylor, D.; Hicks, T.; Champod, C. 2016: Using sensitivity analyses in Bayesian Networks to highlight the impact of data paucity and direct future analyses: a contribution to the debate on measuring and reporting the precision of likelihood ratios Science and Justice: Journal of the Forensic Science Society 56(5): 402-410
Conrad, E.; Rabbach, H. 1979: Results of complex analyses in the ambulatory care area. 2. Working time studies and waiting time analyses in the departments of general dentistry and pedodontics Zeitschrift für Arztliche Fortbildung 73(8): 397-402
Gotto, A.M.; Grundy, S.M. 1999: Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting Circulation 99(8): E1-E7
2012: Costs for traditional meds static while specialty drug costs soar Managed Care 21(6): 47
Peña, C.; Pujol, M.; Pallarés, R.; Corbella, X.; Vidal, T.; Tortras, N.; Ariza, J.; Gudiol, F. 1996: Estimation of costs attributable to nosocomial infection: prolongation of hospitalization and calculation of alternative costs Medicina Clinica 106(12): 441-444